As of May 2024 Insulet has a market cap of $13.11 Billion. This makes Insulet the world's 1339th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $13.11 B | -13.43% |
2023 | $15.15 B | -25.89% |
2022 | $20.44 B | 11.42% |
2021 | $18.35 B | 8.88% |
2020 | $16.85 B | 57.04% |
2019 | $10.73 B | 128.59% |
2018 | $4.69 B | 16.93% |
2017 | $4.01 B | 85.55% |
2016 | $2.16 B | 0.48% |
2015 | $2.15 B | -16.96% |
2014 | $2.59 B | 27.38% |
2013 | $2.03 B | 98.38% |
2012 | $1.02 B | 14.99% |
2011 | $0.89 B | 26.71% |
2010 | $0.70 B | 30.64% |
2009 | $0.53 B | 172.45% |
2008 | $0.19 B | -67.12% |
2007 | $0.60 B |
On May 17th, 2024 the market cap of Insulet was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $372.16 B | 2,737.45% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $181.07 B | 1,280.56% | ๐บ๐ธ USA |
Medtronic MDT | $114.08 B | 769.81% | ๐ฎ๐ช Ireland |
Eli Lilly LLY | $731.81 B | 5,479.41% | ๐บ๐ธ USA |
Tandem Diabetes Care
TNDM | $3.05 B | -76.71% | ๐บ๐ธ USA |
ICU Medical
ICUI | $2.53 B | -80.68% | ๐บ๐ธ USA |
DexCom DXCM | $52.23 B | 298.28% | ๐บ๐ธ USA |